(4-(4-(Cyclopropylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-fluoro-5-methoxyphenyl)(morpholino)methanone

ID: ALA2178135

PubChem CID: 71451847

Max Phase: Preclinical

Molecular Formula: C20H21F4N5O3

Molecular Weight: 455.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C(=O)N2CCOCC2)c(F)cc1Nc1ncc(C(F)(F)F)c(NC2CC2)n1

Standard InChI:  InChI=1S/C20H21F4N5O3/c1-31-16-8-12(18(30)29-4-6-32-7-5-29)14(21)9-15(16)27-19-25-10-13(20(22,23)24)17(28-19)26-11-2-3-11/h8-11H,2-7H2,1H3,(H2,25,26,27,28)

Standard InChI Key:  FKNAWDCGDQUZRV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   24.4621  -31.4660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7481  -31.8705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0464  -30.6447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7522  -30.2361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4607  -28.1931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4595  -29.0126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1676  -29.4216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8772  -29.0121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8744  -28.1895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1658  -27.7842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1674  -30.2388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4596  -30.6472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.8750  -30.6475    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.0430  -31.4625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.1633  -26.9670    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.8698  -26.5563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5766  -26.9652    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2826  -26.5551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2806  -25.7371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5667  -25.3308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8637  -25.7431    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.9914  -26.9620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.9866  -25.3254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6960  -25.7310    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   27.9831  -24.5082    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   28.6884  -24.9120    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   27.9934  -27.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7529  -27.7846    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.7527  -26.9674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5856  -29.4196    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   27.5908  -28.4870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4079  -28.4850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  7 11  1  0
 11 12  1  0
 11 13  2  0
 12  4  1  0
 12  1  1  0
  4  3  1  0
  3 14  1  0
 14  2  1  0
  2  1  1  0
 10 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 18 22  1  0
 19 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
 22 27  1  0
  5 28  1  0
 28 29  1  0
  8 30  1  0
 31 27  1  0
 32 31  1  0
 27 32  1  0
M  END

Associated Targets(Human)

HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatocyte (2737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LRRK2 Tchem Leucine-rich repeat serine/threonine-protein kinase 2 (6390 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasma (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatocyte (2621 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 455.41Molecular Weight (Monoisotopic): 455.1581AlogP: 3.43#Rotatable Bonds: 6
Polar Surface Area: 88.61Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.38CX Basic pKa: 3.38CX LogP: 2.64CX LogD: 2.64
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.65Np Likeness Score: -1.74

References

1. Estrada AA, Liu X, Baker-Glenn C, Beresford A, Burdick DJ, Chambers M, Chan BK, Chen H, Ding X, DiPasquale AG, Dominguez SL, Dotson J, Drummond J, Flagella M, Flynn S, Fuji R, Gill A, Gunzner-Toste J, Harris SF, Heffron TP, Kleinheinz T, Lee DW, Le Pichon CE, Lyssikatos JP, Medhurst AD, Moffat JG, Mukund S, Nash K, Scearce-Levie K, Sheng Z, Shore DG, Tran T, Trivedi N, Wang S, Zhang S, Zhang X, Zhao G, Zhu H, Sweeney ZK..  (2012)  Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.,  55  (22): [PMID:22985112] [10.1021/jm301020q]

Source